This inventor holds 0 USPTO granted patents, plus 14 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Innovations and Contributions of Inventor Hideyuki Okano
Introduction
Hideyuki Okano is a notable inventor based in Japan, recognized for his contributions to the field of biomedical research. His work primarily focuses on human mesenchymal stem cells and methods for treating hearing loss. Despite having no patents registered under his name, his research has significant implications for medical science.
Latest Patents
Okano's latest patents include a method for evaluating the quality of human mesenchymal stem cells and a method for treating hearing loss. The first patent aims to provide a method for evaluating the quality of human mesenchymal stem cells, which includes separating, selecting, and culturing these cells. It also introduces a monoclonal antibody that specifically recognizes rapidly proliferating human mesenchymal stem cells. The second patent addresses methods for treating hearing loss associated with the loss of cochlear hair cells, utilizing certain gamma secretase inhibitors in post-neonatal animals.
Career Highlights
Throughout his career, Hideyuki Okano has worked with prominent institutions such as the Japan Science and Technology Corporation and Keio University. His research has contributed to advancements in regenerative medicine and auditory health.
Collaborations
Okano has collaborated with notable colleagues, including Koki Fujimori and Hironobu Okuno, to further his research endeavors. Their combined expertise has enhanced the impact of their work in the scientific community.
Conclusion
Hideyuki Okano's innovative research and dedication to advancing medical science highlight his importance as an inventor. His contributions, particularly in the fields of stem cell evaluation and hearing loss treatment, continue to influence future developments in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile